国际参考定价是国际上许多国家进行药品价格治理和医保支付管理的重要工具之一。欧盟国家、日本、美国采用了药品国际参考定价方法。我国进行药品价格治理、新药上市价格承诺和首发报价参考国际价格。建议药品国际参考定价在创新药先行试点，并逐步向医保报销药品推开，出台实施细则、审核监督机制，完善价格治理综合体系。

International reference pricing is one of the most important tools in drug price management and payment management. European Union countries, Japan, and the United States have adopted the international reference pricing for drugs. China is implementing drug price management, committing to new drug launch prices, and referencing external prices for initial pricing. It is suggested that international reference pricing for drugs be piloted in innovative drugs and gradually extended to drugs reimbursed by medical insurance. Implementation rules, audit and supervision mechanisms should be introduced to improve the comprehensive system of price governance.

R954